Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Temporal Pattern of Mutations in the Knockdown Resistance (kdr) Gene of Aedes aegypti Mosquitoes Sampled from Southern Taiwan

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Molecular Markers of Plasmodium falciparum Drug Resistance in Parasitemic Pregnant Women in the Middle Forest Belt of Ghana

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Tuberculosis-Related Diabetes: Is It Reversible after Complete Treatment?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Schistosomiasis in European Travelers and Migrants: Analysis of 14 Years TropNet Surveillance Data

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Do-not-resuscitate orders in patients with community-acquired pneumonia: a retrospective study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-term risk of tuberculosis among migrants according to migrant status: a cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Mortality and admission to intensive care units after febrile neutropenia in patients with cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Interferon-gamma (IFN-γ) release assays (IGRAs) are used to detect cellular immune recognition of Mycobacterium tuberculosis. The chemokine IFN-γ-inducible protein 10 (IP-10) is an alternative diagnostic biomarker to IFN-γ. Several conditions interfere with IGRA test performance. We aimed to assess the possible influence of Plasmodium falciparum infection on the IGRA test QuantiFERON-TB GOLD(®) In-Tube (QFT) test and an in-house IP-10 release assay. In total, 241 Tanzanian adults were included; 184 patients with uncomplicated malaria (88 human immunodeficiency virus [HIV] coinfected) and 57 HIV-infected patients without malaria infection. Malaria was treated with artemether-lumefantrine (Coartem(®)). QFT testing was performed before initiation of malaria treatment and at days 7 and 42. In total, 172 patients completed follow-up. IFN-γ and IP-10 was measured in QFT supernatants. We found that during malaria infection IFN-γ and IP-10 levels in the unstimulated samples were elevated, mitogen responsiveness was impaired, and CD4 cell counts were decreased. These alterations reverted after malaria treatment. Concurrent malaria infection did not affect QFT test results, whereas there were more indeterminate IP-10 results during acute malaria infection. We suggest that IGRA and IP-10 release assay results of malaria patients should be interpreted with caution and that testing preferably should be postponed until after malaria treatment.

OriginalsprogEngelsk
TidsskriftThe American journal of tropical medicine and hygiene
Vol/bind94
Udgave nummer4
Sider (fra-til)728-35
ISSN0002-9637
DOI
StatusUdgivet - 2016

ID: 46179669